UK Private Equity houses

Start-ups in the life science sector are a source of invaluable innovation, entrepreneurial spirit and ultimately, important developments that could improve patient health. It is through new ideas that the sector can face current and future challenges, such as an ageing population, the need to invest in new-generation, digitalised technology, and a rise in patient demand of service and value for money. But data shows that 90% of all start-ups fail within the first year, a worrying statistic considering the wealth of advantages that innovation can bring to the life sciences industry...

Read More »